A recent study used tissue derived from IPF patients to examine the activity of a PI3K/mammalian target of rapamycin (mTOR) inhibitor and showed that this inhibited Akt phosphorylation59. This evidence concerns the gene AKT1 and idiopathic pulmonary fibrosis.